This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Miller, G Articles by Pagano, J Search for Related Content PubMed PubMed Citation Articles by Miller, G Articles by Pagano, J

Biological properties and viral surface antigens of Burkitt lymphoma- and mononucleosis- derived strains of Epstein-Barr virus released from transformed marmoset cells.

ABSTRACT

Three strains of Epstein-Barr virus (EBV), two from Burkitt lymphoma (BL) and one from infectious mononucleosis (IM) were used to transform separate cultures of the same batch of primary marmoset leukocytes, and the viruses released from the transformants were compared. The three viruses shared properties of the transforming biotype of EBV, namely, stimulation of DNA synthesis and immortalization of cord blood leukocytes, and failure to induce "early antigen" in lymphoblast lines. All viruses produced more virus in transformed marmoset cells than in transformed human cells, as measured by the number of EBV genomes detected by complementary RNA/DNA hybridization, by virus capsid antigen expression, or by released virions and biologically active virus. Reference human sera and sera from primary EBV infections were used to compare the three virus strains in a virus neutralization test based on inhibition of stimulation of DNA synthesis. Specimens taken late in convalescence from patients with mononucleosis and sera from marmosets experimentally infected with virus from a patient with mononucleosis neutralized the homologous virus, as well as the two virus strains isolated from patients with BL. This finding indicates that viral antigens that elicit neutralizing antibodies are shared among the strains. However, in certain sera the neutralizing-antibody titer against one strain was consistently higher than against another strain. Furthermore, sera taken early after onset of IM contained low levels of neutralizing antibody against IM-derived virus, but failed to neutralize BL-derived virus. These latter findings suggest the existence of heterogeneity among surface antigens of EBVs. The results emphasize the biological and antigenic similarity of EBV isolates from BL and IM and do not suggest major subtype variations. It remains to be determined whether antigenic diversity such as described or virus genome variation detectable by other means is epidemiologically significant.

This article has been cited by other articles:

• Zeng, M.-S., Li, D.-J., Liu, Q.-L., Song, L.-B., Li, M.-Z., Zhang, R.-H., Yu, X.-J., Wang, H.-M., Ernberg, I., Zeng, Y.-X. (2005). Genomic Sequence Analysis of Epstein-Barr Virus Strain GD1 from a Nasopharyngeal Carcinoma Patient. J. Virol. 79: 15323-15330 [Abstract] [Full Text]  
• Gradoville, L., Kwa, D., El-Guindy, A., Miller, G. (2002). Protein Kinase C-Independent Activation of the Epstein-Barr Virus Lytic Cycle. J. Virol. 76: 5612-5626 [Abstract] [Full Text]  
• Yoo, L., Speck, S. H. (2000). Determining the Role of the Epstein-Barr Virus Cp EBNA2-Dependent Enhancer during the Establishment of Latency by Using Mutant and Wild-Type Viruses Recovered from Cottontop Marmoset Lymphoblastoid Cell Lines. J. Virol. 74: 11115-11120 [Abstract] [Full Text]  
• Ometto, L., Menin, C., Masiero, S., Bonaldi, L., Del Mistro, A., Cattelan, A. M., D'Andrea, E., De Rossi, A., Chieco-Bianchi, L. (1997). Molecular Profile of Epstein-Barr Virus in Human Immunodeficiency Virus Type 1-Related Lymphadenopathies and Lymphomas. Blood 90: 313-322 [Abstract] [Full Text]